AERPIO PHARMACEUTICALS INC's ticker is ARPO and the CUSIP is 00810B105. A total of 26 filers reported holding AERPIO PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $94,000 | +30.6% | 55,602 | 0.0% | 0.00% | – |
| Q1 2021 | $72,000 | +33.3% | 55,602 | 0.0% | 0.00% | – |
| Q4 2020 | $54,000 | -36.5% | 55,602 | -1.7% | 0.00% | – |
| Q3 2020 | $85,000 | +34.9% | 56,547 | +12.6% | 0.00% | – |
| Q2 2020 | $63,000 | +117.2% | 50,200 | -4.9% | 0.00% | – |
| Q1 2020 | $29,000 | -12.1% | 52,764 | 0.0% | 0.00% | – |
| Q4 2019 | $33,000 | -8.3% | 52,764 | 0.0% | 0.00% | – |
| Q3 2019 | $36,000 | -25.0% | 52,764 | 0.0% | 0.00% | – |
| Q2 2019 | $48,000 | 0.0% | 52,764 | 0.0% | 0.00% | – |
| Q1 2019 | $48,000 | – | 52,764 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 5,621,835 | $9,501,000 | 5.16% |
| ABG Innovation Capital Partners III GP Ltd | 400,000 | $676,000 | 2.26% |
| Ikarian Capital, LLC | 1,676,093 | $2,832,000 | 0.23% |
| Avoro Capital Advisors LLC | 4,500,000 | $7,605,000 | 0.13% |
| Parkman Healthcare Partners LLC | 353,957 | $598,000 | 0.13% |
| Orbimed Advisors | 5,193,946 | $8,778,000 | 0.09% |
| RA Capital Management | 2,693,309 | $4,552,000 | 0.07% |
| Atom Investors LP | 79,996 | $135,000 | 0.02% |
| NEVILLE RODIE & SHAW INC | 100,000 | $169,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 208,674 | $353,000 | 0.01% |